Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Torrent Pharmaceuticals Ltd.

www.torrentpharma.com

Latest From Torrent Pharmaceuticals Ltd.

Torrent Drops In US But Grows In India

With overall revenues up by 6% to INR20.05bn, Torrent delivered mixed results in its financial second quarter. The company is maintaining its focus on R&D investment.

Sales & Earnings Strategy

Alembic Gets Sartans Shot In Q2

The continuing sartans crisis and new product launches in US helped Alembic to post a strong Q2 performance, despite slowdown in other markets.

Sales & Earnings Strategy

Alembic Q2 Gets Sartans Shot

Continuing sartans crisis, new product launches in US help Alembic post strong Q2 performance despite slowdown in other markets.

India Sales & Earnings

US FDA Warns Torrent Over Losartan Process Validation, OOS Invalidation Failures

Warning letter stemming from global nitrosamine investigation raises new concerns about Indian manufacturer.

Quality Enforcement
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Torrent Pharmaceuticals Ltd.
  • Senior Management
  • Sudhir Mehta, Chmn.
  • Contact Info
  • Torrent Pharmaceuticals Ltd.
    Phone: (91) 79-26599000
    Torrent House, Off. Ashram Rd.
    Ahmedabad, 380 009
    India
UsernamePublicRestriction

Register